Log In
Print
BCIQ
Print
Print this Print this
 

Perjeta, pertuzumab (R1273, RG1273)

Also known as: Omnitarg (2C4) (formerly rhuMAb-2C4)

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionHumanized mAb HER dimerization inhibitor that prevents HER2 from binding to other HER receptors (HER1/EGF, HER3 and HER4)
Molecular Target Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today